Table of Contents Author Guidelines Submit a Manuscript
Pathology Research International
Volume 2012, Article ID 350309, 6 pages
http://dx.doi.org/10.1155/2012/350309
Review Article

Clinicopathological Features and Management of Cancers in Lynch Syndrome

Department of Gastroenterological Surgery, Jyväskylä Central Hospital, 40620 Jyväskylä, Finland

Received 2 December 2011; Accepted 28 February 2012

Academic Editor: George L. Mutter

Copyright © 2012 Markku Aarnio. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Aaltonen, L. Johns, H. Järvinen, J. P. Mecklin, and R. Houlston, “Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors,” Clinical Cancer Research, vol. 13, no. 1, pp. 356–361, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. T. Lynch and A. de la Chapelle, “Hereditary colorectal cancer,” New England Journal of Medicine, vol. 348, no. 10, pp. 919–932, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. W. M. Abdel-Rahman, J. P. Mecklin, and P. Peltomaki, “The genetics of HNPCC: application to diagnosis and screening,” Critical Reviews in Oncology / Hematology, vol. 58, no. 3, pp. 208–220, 2006. View at Google Scholar
  4. H. T. Lynch and T. Smyrk, “Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review,” Cancer, vol. 78, no. 6, pp. 1149–1167, 1996. View at Google Scholar
  5. M. Aarnio, R. Sankila, E. Pukkala et al., “Cancer risk in mutation carriers of DNA-mismatch-repair genes,” International Journal of Cancer, vol. 81, no. 2, pp. 214–218, 1999. View at Google Scholar · View at Scopus
  6. P. Watson, H. F. A. Vasen, J. P. Mecklin et al., “The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome,” International Journal of Cancer, vol. 123, no. 2, pp. 444–449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. F. A. Vasen, J. P. Mecklin, P. Meera Khan, and H. T. Lynch, “The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC),” Diseases of the Colon and Rectum, vol. 34, no. 5, pp. 424–425, 1991. View at Google Scholar · View at Scopus
  8. H. F. A. Vasen, P. Watson, J. P. Mecklin, and H. T. Lynch, “New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC,” Gastroenterology, vol. 116, no. 6, pp. 1453–1456, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Rodriguez-Bigas, C. R. Boland, S. R. Hamilton et al., “A national cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines,” Journal of the National Cancer Institute, vol. 89, no. 23, pp. 1758–1762, 1997. View at Google Scholar · View at Scopus
  10. A. Umar, C. R. Boland, J. P. Terdiman et al., “Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability,” Journal of the National Cancer Institute, vol. 96, no. 4, pp. 261–268, 2004. View at Google Scholar · View at Scopus
  11. H. J. Järvinen, M. Aarnio, H. Mustonen et al., “Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer,” Gastroenterology, vol. 118, no. 5, pp. 829–834, 2000. View at Google Scholar · View at Scopus
  12. R.-S. Laura, R. Butzow, A. Leminen, P. lehtovirtsa, J. P. Mecklin, and H. J. Järvinen, “Surveillance for endometrial cancer in hereditary nonplyposis colorectal cancer syndrome,” International Journal of Cancer, vol. 120, no. 4, pp. 821–824, 2006. View at Google Scholar
  13. P. Peltomäki and H. Vasen, “Mutations associated with HNPCC predisposition-update of ICG-HNPCC/INSiGHT mutation database,” Disease Markers, vol. 20, no. 4-5, pp. 269–276, 2004. View at Google Scholar · View at Scopus
  14. P. Peltomäki, “Role of DNA mismatch repair defects in the pathogenesis of human cancer,” Journal of Clinical Oncology, vol. 21, no. 6, pp. 1174–1179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Aaltonen, P. Peltomaki, F. S. Leach et al., “Clues to the pathogenesis of familial colorectal cancer,” Science, vol. 260, no. 5109, pp. 812–816, 1993. View at Google Scholar · View at Scopus
  16. L. A. Aaltonen, P. Peltomaki, J. P. Mecklin et al., “Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients,” Cancer Research, vol. 54, no. 7, pp. 1645–1648, 1994. View at Google Scholar · View at Scopus
  17. M. van den Bos, M. Van Den Hoven, E. Jongejan et al., “More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon,” American Journal of Surgical Pathology, vol. 28, no. 6, pp. 706–711, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Gylling, W. M. Abdel-Rahman, M. Juhola et al., “Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? a molecular genetic study,” Gut, vol. 56, no. 7, pp. 926–933, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. H. S. Gylling, T. T. Nieminen, W. M. Abdel-Rahman et al., “Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors,” Carcinogenesis, vol. 29, no. 7, pp. 1351–1359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. F. A. Vasen, J. T. Wijnen, F. H. Menko et al., “Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis,” Gastroenterology, vol. 110, no. 4, pp. 1020–1027, 1996. View at Google Scholar · View at Scopus
  21. J. P. Mecklin and H. J. Jarvinen, “Clinical features of colorectal carcinoma in cancer family syndrome,” Diseases of the Colon and Rectum, vol. 29, no. 3, pp. 160–164, 1986. View at Google Scholar · View at Scopus
  22. H. F. A. Vasen, G. J. A. Offerhaus, F. C. A. Den Hartog Jager et al., “The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in The Netherlands,” International Journal of Cancer, vol. 46, no. 1, pp. 31–34, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. M. G. Dunlop, S. M. Farrington, A. D. Carothers et al., “Cancer risk associated with germline DNA mismatch repair gene mutations,” Human Molecular Genetics, vol. 6, no. 1, pp. 105–110, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. M. C. Hendriks, A. Wagner, H. Morreau et al., “Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance,” Gastroenterology, vol. 127, no. 1, pp. 17–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-P. Mecklin, M. Aarnio, E. Läärä et al., “Development of colorectal tumors in colonoscopic surveillance in Lynch Syndrome,” Gastroenterology, vol. 133, no. 4, pp. 1093–1098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. J. P. Mecklin, P. Sipponen, and H. J. Jarvinen, “Histopathology of colorectal carcinomas and adenomas in cancer family syndrome,” Diseases of the Colon and Rectum, vol. 29, no. 12, pp. 849–853, 1986. View at Google Scholar · View at Scopus
  27. H. T. Lynch, T. C. Smyrk, P. Watson et al., “Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review,” Gastroenterology, vol. 104, no. 5, pp. 1535–1549, 1993. View at Google Scholar · View at Scopus
  28. J. R. Jass, “Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer,” Histopathology, vol. 27, no. 3, pp. 263–267, 1995. View at Google Scholar · View at Scopus
  29. S. J. Lanspa, H. T. Lynch, T. C. Smyrk et al., “Colorectal adenomas in the Lynch syndromes: results of a colonoscopy screening program,” Gastroenterology, vol. 98, no. 5, pp. 1117–1122, 1990. View at Google Scholar · View at Scopus
  30. P. Gaglia, W. S. Atkin, S. Whitelaw et al., “Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer,” Gut, vol. 36, no. 3, pp. 385–390, 1995. View at Google Scholar · View at Scopus
  31. A. E. de Jong, H. Morreau, M. Van Puijenbroek et al., “The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC,” Gastroenterology, vol. 126, no. 1, pp. 42–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. H. F. A. Vasen, F. M. Nagengast, and P. Meera Khan, “Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome),” The Lancet, vol. 345, no. 8958, pp. 1183–1184, 1995. View at Google Scholar · View at Scopus
  33. M. Kouri, A. Laasonen, J. P. Mecklin, H. Jarvinen, K. Franssila, and S. Pyrhonen, “Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry,” Cancer, vol. 65, no. 8, pp. 1825–1829, 1990. View at Google Scholar · View at Scopus
  34. H. F. A. Vasen, G. Möslein, A. Alonso et al., “Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer),” Journal of Medical Genetics, vol. 44, no. 6, pp. 353–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Natarajan, P. Watson, E. Silva-Lopez, and H. T. Lynch, “Comparison of extended colectomy and limited resection in patients with lynch syndrome,” Diseases of the Colon and Rectum, vol. 53, no. 1, pp. 77–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. Church, “Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer,” Annals of Medicine, vol. 28, no. 6, pp. 479–482, 1996. View at Google Scholar · View at Scopus
  37. H. J. Järvinen and M. Aarnio, “Surveillance on mutation carriers of DNA mismatch repair genes,” Annales Chirurgiae et Gynaecologiae, vol. 89, no. 3, pp. 207–210, 2000. View at Google Scholar · View at Scopus
  38. R. Sankila, L. A. Aaltonen, H. J. Jarvinen, and J. P. Mecklin, “Better survival rates in patients with MLH1-associated hereditary colorectal cancer,” Gastroenterology, vol. 110, no. 3, pp. 682–687, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Watson, K. M. Lin, M. A. Rodriquez-Bigas, T. Smyrk, S. Lemon, and M. Shadhisharan, “Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members,” Cancer, vol. 83, no. 2, pp. 259–266, 1998. View at Google Scholar
  40. H. Kim, J. Jen, B. Vogelstein, and S. R. Hamilton, “Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences,” American Journal of Pathology, vol. 145, no. 1, pp. 148–156, 1994. View at Google Scholar · View at Scopus
  41. D. Shibata, M. A. Peinado, Y. Ionov, S. Malkhosyan, and M. Perucho, “Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation,” Nature Genetics, vol. 6, no. 3, pp. 273–281, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Flossmann and P. M. Rothwell, “Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies,” The Lancet, vol. 369, no. 9573, pp. 1603–1613, 2007. View at Publisher · View at Google Scholar
  43. J. Cuzick, F. Otto, J. A. Baron et al., “Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement,” The Lancet Oncology, vol. 10, no. 5, pp. 501–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Burn, A.-M. Gerdes, F. Macrae et al., “Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled study,” The Lancet, vol. 378, no. 9809, pp. 2081–2087, 2011. View at Publisher · View at Google Scholar
  45. M. Aarnio, J. P. Mecklin, L. A. Aaltonen, M. Nystrom-Lahti, and H. J. Jarvinen, “Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome,” International Journal of Cancer, vol. 64, no. 6, pp. 430–433, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. M. G. Dunlop, S. M. Farrington, A. D. Carothers et al., “Cancer risk associated with germline DNA mismatch repair gene mutations,” Human Molecular Genetics, vol. 6, no. 1, pp. 105–110, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. R. R. Broaddus, H. T. Lynch, L. M. Chen et al., “Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma,” Cancer, vol. 106, no. 1, pp. 87–94, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. D. E. S. Boks, A. P. Trujillo, A. C. Voogd, H. Morreau, G. G. Kenter, and H. F. A. Vasen, “Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer,” International Journal of Cancer, vol. 102, no. 2, pp. 198–200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Dove-Edwin, D. Boks, S. Goff et al., “The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma,” Cancer, vol. 94, no. 6, pp. 1708–1712, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. F. E. Rijcken, M. J. Mourits, J. H. Kleibeuker, H. Hollema, and A. G. van der Zee, “Gynekologic screening in hereditary nonpolyposis colorectal cancer,” Gynecologic Oncology, vol. 91, no. 1, pp. 74–80, 2003. View at Google Scholar
  51. T. T. Nieminen, A. Gylling, W. M. Abdel-Rahman et al., “Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia,” Clinical Cancer Research, vol. 15, no. 18, pp. 5772–5783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. J. J. Koornstra, M. J. Mourits, R. H. Sijmons, A. M. Leliveld, H. Hollema, and J. H. Kleibeuker, “Management of extracolonic tumours in patients with Lynch syndrome,” The Lancet Oncology, vol. 10, no. 4, pp. 400–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. H. F. A. Vasen, A. Stormorken, F. H. Menko et al., “MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families,” Journal of Clinical Oncology, vol. 19, no. 20, pp. 4074–4080, 2001. View at Google Scholar · View at Scopus
  54. M. Aarnio, R. Salovaara, L. A. Aaltonen, J. P. Mecklin, and H. J. Järvinen, “Features of gastric cancers in hereditary non-polyposis colorectal cancer syndrome,” International Journal of Cancer, vol. 74, pp. 551–555, 1997. View at Google Scholar
  55. J. Lehtola, “Family study of gastric carcinoma: with special reference to histological types,” Scandinavian Journal of Gastroenterology, vol. 13, supplement 50, pp. 1–54, 1978. View at Google Scholar
  56. L. Renkonen-Sinisalo, P. Sipponen, M. Aarnio et al., “No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer,” Scandinavian Journal of Gastroenterology, vol. 37, no. 5, pp. 574–577, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. R. S. van der Post, L. A. Kiemeney, M. J. L. Ligtenberg et al., “Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers,” Journal of Medical Genetics, vol. 47, no. 7, pp. 464–470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Myrhoj, M. B. Andersen, and I. Bernstein, “Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer,” Familial Cancer, vol. 7, no. 4, pp. 303–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. E. M. Grindedal, L. Renkonen-Sinisalo, H. Vasen et al., “Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds,” Journal of Medical Genetics, vol. 47, no. 2, pp. 99–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. J. P. Mecklin, H. J. Jarvinen, and M. Virolainen, “The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma,” Cancer, vol. 69, no. 5, pp. 1112–1114, 1992. View at Google Scholar · View at Scopus
  61. K. Schulmann, F. E. Brasch, E. Kunstmann et al., “HNPCC-associated small bowel cancer: clinical and molecular characteristics,” Gastroenterology, vol. 128, no. 3, pp. 590–599, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. M. A. Rodriquez-Bigas, H. F. A. Vasen, H. T. Lynch et al., “Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma,” Cancer, vol. 83, no. 2, pp. 240–244, 1998. View at Google Scholar
  63. H. F. A. Vasen, E. A. C. M. Sanders, B. G. Taal et al., “The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC),” International Journal of Cancer, vol. 65, no. 4, pp. 422–425, 1996. View at Google Scholar